163 related articles for article (PubMed ID: 34529780)
1. Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation.
Sajulga R; Bolon YT; Maiers MJ; Petersdorf EW
Blood Adv; 2022 Jan; 6(1):270-280. PubMed ID: 34529780
[TBL] [Abstract][Full Text] [Related]
2. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
Petersdorf EW; Carrington M; O'hUigin C; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Maiers MJ; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P;
Lancet Haematol; 2020 Jan; 7(1):e50-e60. PubMed ID: 31669248
[TBL] [Abstract][Full Text] [Related]
3. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation.
Petersdorf EW; Stevenson P; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Carrington M
Blood; 2020 Jul; 136(3):362-369. PubMed ID: 32483623
[TBL] [Abstract][Full Text] [Related]
4. HLA-B leader genotypes in a clinical population.
Balgansuren G; Sprague M; Peterson P; Shenavar Y; Ng A; Regen L; Shelton N; Petersdorf E
HLA; 2023 Jul; 102(1):44-51. PubMed ID: 36929133
[TBL] [Abstract][Full Text] [Related]
5. Use of the HLA-B leader to optimize cord blood transplantation.
Petersdorf EW; Gooley T; Volt F; Kenzey C; Madrigal A; McKallor C; Querol S; Rafii H; Rocha V; Tamouza R; Chabannon C; Ruggeri A; Gluckman E
Haematologica; 2021 Dec; 106(12):3107-3114. PubMed ID: 33121238
[TBL] [Abstract][Full Text] [Related]
6. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
7. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
8. Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kröger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
Front Immunol; 2020; 11():584520. PubMed ID: 33542712
[TBL] [Abstract][Full Text] [Related]
9. MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.
Petersdorf EW; Malkki M; Gooley TA; Spellman SR; Haagenson MD; Horowitz MM; Wang T
Sci Transl Med; 2012 Jul; 4(144):144ra101. PubMed ID: 22837536
[TBL] [Abstract][Full Text] [Related]
10. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
[TBL] [Abstract][Full Text] [Related]
11. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
[TBL] [Abstract][Full Text] [Related]
14. Race and Survival in Unrelated Hematopoietic Cell Transplantation.
Morishima Y; Morishima S; Stevenson P; Kodera Y; Horowitz M; McKallor C; Malkki M; Spellman SR; Gooley T; Petersdorf EW;
Transplant Cell Ther; 2022 Jul; 28(7):357.e1-357.e6. PubMed ID: 35405366
[TBL] [Abstract][Full Text] [Related]
15. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
16. [Implications of HLA in allogeneic stem cell transplantation].
Morishima S
Rinsho Ketsueki; 2019; 60(9):1324-1330. PubMed ID: 31597859
[TBL] [Abstract][Full Text] [Related]
17. MHC haplotype matching for unrelated hematopoietic cell transplantation.
Petersdorf EW; Malkki M; Gooley TA; Martin PJ; Guo Z
PLoS Med; 2007 Jan; 4(1):e8. PubMed ID: 17378697
[TBL] [Abstract][Full Text] [Related]
18. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
19. How to select the best available related or unrelated donor of hematopoietic stem cells?
Tiercy JM
Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
